Metformin Zentiva

Metformin Hydrochloride, the active ingredient in Metformin Zentiva, is a biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus, helping to lower both fasting and post‑prandial glucose levels.

GNH USA supplies Metformin Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets European Union quality standards, is manufactured under GMP conditions, and is distributed through a secure global logistics network ensuring timely delivery.

Metformin Zentiva is indicated for the management of type 2 diabetes mellitus, a chronic metabolic disorder characterized by insulin resistance.

- Type 2 diabetes mellitus: improves glycemic control by reducing hepatic glucose production and enhancing peripheral insulin sensitivity.

Metformin Zentiva may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often transient. - Abdominal discomfort: cramping or pain. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycemia: when combined with other glucose‑lowering agents. - Vitamin B12 deficiency: long‑term use may reduce absorption. - Acute pancreatitis: inflammation of the pancreas.

When prescribing Metformin Zentiva, clinicians should consider several safety factors.

- Renal function: assess eGFR before initiating and monitor periodically. - Hepatic disease: avoid in patients with severe liver impairment. - Alcohol consumption: limit intake to reduce lactic acidosis risk. - Pregnancy: use only if potential benefit justifies potential risk. - Elderly patients: monitor for accumulation and renal decline. - Store at ambient temperature: keep in the original pack, protect from moisture.

Metformin Zentiva can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute kidney injury. - Cimetidine: can increase metformin plasma concentrations. - Nitrates: combined use may raise risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes.